ABCA10 and breast carcinoma: As shown in Figure 10B, we found that the scores of Lypressin and ABCA10 KD on breast cancer cells (MCF7) were 0.39 and 0.27, respectively, indicating a positive correlation between the average transcriptional effect of ABCA10 expression and Lypressin drug activity.